Rebuttal to "Causal effect of vitamin D on prostate cancer using Mendelian randomization approach"

Affiliations

¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
² Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, 8036, Graz, Austria. wilfried.renner@medunigraz.at.
³ Department of Therapeutic Radiology and Oncology, Medical University of Graz, Graz, Austria.

Comment

Olivia Trummer et al. World J Urol. 2016 Apr.

. 2016 Apr;34(4):615.

doi: 10.1007/s00345-015-1681-6. Epub 2015 Sep 21.

¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
² Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, 8036, Graz, Austria. wilfried.renner@medunigraz.at.
³ Department of Therapeutic Radiology and Oncology, Medical University of Graz, Graz, Austria.

No abstract available

Comment on

Vitamin D and prostate cancer prognosis: a Mendelian randomization study.
Trummer O, Langsenlehner U, Krenn-Pilko S, Pieber TR, Obermayer-Pietsch B, Gerger A, Renner W, Langsenlehner T. Trummer O, et al. World J Urol. 2016 Apr;34(4):607-11. doi: 10.1007/s00345-015-1646-9. Epub 2015 Jul 25. World J Urol. 2016. PMID: 26209090 Clinical Trial.
Causal effect of vitamin D on prostate cancer using Mendelian randomization approach.
Yu H, Xu P, Cui Y. Yu H, et al. World J Urol. 2016 Apr;34(4):613-4. doi: 10.1007/s00345-015-1672-7. Epub 2015 Aug 21. World J Urol. 2016. PMID: 26293118 No abstract available.